EU must put human-relevant science at heart of pharmaceutical strategy
Our recommendation to Commission consultation assessing impact of Europe’s pharmaceutical legislation
"90% of drugs fail in clinical trials on humans despite having passed pre-clinical studies, including extensive tests in animals."
- Places humane and human-relevant preclinical assessment at the heart of its strategy.
- Moves away from the current outdated and unreliable animal testing paradigm.
- Prioritises investment in modern and human-relevant methods.
- Sets targets to phase out animal testing.